Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin

被引:104
|
作者
Espinel-Ingroff, A.
Arthington-Skaggs, B.
Iqbal, N.
Ellis, D.
Pfaller, M. A.
Messer, S.
Rinaldi, M.
Fothergill, A.
Gibbs, D. L.
Wang, A.
机构
[1] Virginia Commonwealth Univ, Med Ctr, Richmond, VA 23298 USA
[2] Ctr Dis Control, Atlanta, GA 30333 USA
[3] Womens & Childrens Hosp, Adelaide, SA, Australia
[4] Univ Iowa, Iowa City, IA USA
[5] Univ Texas San Antonio, San Antonio, TX 78285 USA
[6] Giles Sci Inc, Santa Barbara, CA USA
关键词
D O I
10.1128/JCM.00134-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to correlate inhibition zone diameters, in millimeters (agar diffusion disk method), with the broth dilution MICs or minimum effective concentrations (MECs) (CLSI M38-A method) of five antifungal agents to identify optimal testing guidelines for disk mold testing. The following disk diffusion testing parameters were evaluated for 555 isolates of the molds Absidia corymbifera,Aspergillus sp. (five species), Alternaria sp., Bipolaris spicifera, Fusarium sp. (three species), Mucor sp. (two species), Paecilomyces lilacinus, Rhizopus sp. (two species), and Scedosporium sp. (two species): (i) two media (supplemented Mueller-Hinton agar [2% dextrose and 0.5 mu g/ml methylene blue] and plain Mueller-Hinton [MH] agar), (ii) three incubation times (16 to 24, 48, and 72 h), and (iii) seven disks (amphotericin B and itraconazole 10-mu g disks, voriconazole 1- and 10-mu g disks, two sources of caspofungin 5-mu g disks [BBL and Oxoid], and posaconazole 5-mu g disks). MH agar supported better growth of all of the species tested (24 to 48 h). The reproducibility of zone diameters and their correlation with either MICs or MECs (caspofungin) were superior on MH agar (91 to 100% versus 82 to 100%; R, 0.71 to 0.93 versus 0.53 to 0.96 for four of the five agents). Based on these results, the optimal testing conditions for mold disk diffusion testing were (i) plain MH agar; (ii) incubation times of 16 to 24 h (zygomycetes), 24 h (Aspergillus fiumigatus, A. flavus, and A. niger), and 48 h (other species); and (iii) the posaconazole 5-mu g disk, voriconazole 1-mu g disk, itraconazole 10-mu g disk (for all except zygomycetes), BBL caspofungin 5-mu g disk, and amphotericin B 10-mu g (zygomycetes only).
引用
收藏
页码:1811 / 1820
页数:10
相关论文
共 50 条
  • [21] Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi
    Messer, Shawn A.
    Diekema, Daniel J.
    Hollis, Richard J.
    Boyken, Linda B.
    Tendolkar, Shailesh
    Kroeger, Jennifer
    Pfaller, Michael A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (04) : 1322 - 1324
  • [22] Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole
    Silvanose, C. D.
    Bailey, T. A.
    Di Somma, A.
    VETERINARY RECORD, 2006, 159 (09) : 282 - 284
  • [23] In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications
    McGinnis, MR
    Pasarell, L
    JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (08) : 2353 - 2355
  • [24] In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates
    Lacroix, Claire
    de Chauvin, Martine Feuilhade
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 835 - 837
  • [25] In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs
    Drogari-Apiranthitou, Maria
    Mantopoulou, Foteini-Despina
    Skiada, Anna
    Kanioura, Lambrini
    Grammatikou, Maria
    Vrioni, Georgia
    Mitroussia-Ziouva, Aggeliki
    Tsakris, Athanassios
    Petrikkos, George
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (08) : 1937 - 1940
  • [26] Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus
    Manavathu, EK
    Abraham, OC
    Chandrasekar, PH
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (03) : 130 - 137
  • [27] Clinical evaluation of the sensititre YeastOne plate for testing susceptibility of filamentous fungi to posaconazole
    Patel, Reena
    Mendrick, Cara
    Knapp, Cindy C.
    Grist, Roger
    McNicholas, Paul M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (06) : 2000 - 2001
  • [28] EVALUATION OF A RAPID INOCULUM PREPARATION METHOD FOR AGAR DISK DIFFUSION SUSCEPTIBILITY TESTING
    DAMATO, RF
    HOCHSTEIN, L
    JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 15 (02) : 282 - 285
  • [29] Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus
    Arikan, Sevtap
    Sancak, Banu
    Alp, Sehnaz
    Hascelik, Gulsen
    Mcnicholas, Paul
    MEDICAL MYCOLOGY, 2008, 46 (06) : 567 - 573
  • [30] Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin
    Ozdemir, Havva Gul
    Oz, Yasemin
    Ilkit, Macit
    Kiraz, Nuri
    MEDICAL MYCOLOGY, 2012, 50 (02) : 130 - 135